Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

John Wiley & Sons (WLY) Total Liabilities (2016 - 2026)

John Wiley & Sons (WLY) has disclosed Total Liabilities for 17 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 328.6% to $1.7 billion in Q4 2025 year-over-year; TTM through Oct 2025 was $1.7 billion, a 328.6% increase, with the full-year FY2025 number at $1.9 billion, down 2.34% from a year prior.
  • Total Liabilities was $1.7 billion for Q4 2025 at John Wiley & Sons, down from $1.8 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $2.4 billion in Q1 2021 to a low of -$755.3 million in Q4 2024.
  • A 5-year average of $1.8 billion and a median of $2.1 billion in 2022 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: crashed 139.51% in 2024, then skyrocketed 350.99% in 2025.
  • John Wiley & Sons' Total Liabilities stood at $2.2 billion in 2021, then dropped by 8.43% to $2.1 billion in 2022, then fell by 6.77% to $1.9 billion in 2023, then tumbled by 139.51% to -$755.3 million in 2024, then surged by 328.6% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for WLY's Total Liabilities are $1.7 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.9 billion (Q2 2025).